| Actual |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > News and Society > Politics > NSA Whistleblower Explains Tactics |
|
Actual - NSA Whistleblower Explains Tactics
The so called whistle blower was explaining the tactics of the NSA on TV and said that if someone was talking According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product to Al Queda and that someone also called many other people, then those other people they had been in contact m ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ight also be put on surveillance. Now then this brings up an interesting topic. Lets just say that some who ha lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ppened to be talking to Al Queda also was talking to you? Bummer right? I mean now they are tapping your phone here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe lines and going thru all the phones calls in all the phone records and all your emails that you have ever made d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro that are available. Now then what if they went thru all those phone records of everyone you ever called and a ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ll the people they called to see if there was a link somewhere? Might be a good idea correct? Sure in theory easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi t might, however using this scenario one might also consider theories on the degrees of separation; for instan nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ce if the average person knows thirty-five hundred people and some people may know as many as 10,000 people. ( and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ I do). Then if we multiply the 10,000 times 3500 we get 35 million and if we multiply that by another 3500 the ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi we get everyone on the Planet. So going with such a scenario as described by “Joe Whistleblower” you may as ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a well simply put the entire human population on a watch list. Thus you will need a very large computer or many dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod of them. Thus selling computer systems to the NSA must be a very good business indeed. The NSA Whistleblower d cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin escribes a web program and explained how it worked, pretty smart way to do it right? Sure it makes sense, as t tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen is is how human groups are formed. So, if we are all connected by a spider web then one ought to also think a t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel long the lines of monitoring everyone in that web or here on the web? Interesting indeed. So why haven't we al ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ready rounded up all these International Terrorists then? Too much data? You know the late Sam Walton discusse y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products over kill in data collection, before data mining was even a buzzword. Where are the International Terrorists . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de and who are they working for and why haven’t we caught them all by now if this is level of surveillance is rea elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip lly going on? Too tough of a question; okay forget I asked, let someone else ask it then. Think on this in 200 tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:What Actually Happens When You Enter That Web Address In Your Browser? 188 Stage Hero's Journey (Monomyth)- Hero's Journey- Culprit Need For Speed: The Evolving Racing Game
|